Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patientsGeoffroy Venton, Régis Costello, Mihai Turcanu et al.|European Journal of Internal Medicine|2019Cited by 25
Body mass index affects imatinib exposure: Real‐world evidence from TDM with adaptive dosingPaul Maroselli, Joseph Ciccolini, Raphaëlle Fanciullino et al.|Fundamental and Clinical Pharmacology|2025Cited by 8
Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of BCR::ABL1-Negative Myeloproliferative NeoplasmNorman Abbou, Geoffroy Venton, Jean Gabert et al.|Cells|2022Cited by 5
Could daratumumab induce the maturation of plasmablasts in Plasmablastic lymphoma?—Potential therapeutic applicationsPauline Roché, Laure Farnault, Geoffroy Venton et al.|European Journal Of Haematology|2021Cited by 4
Efficacy and safety of autologous stem cell transplantation after induction therapy with lenalidomide, bortezomib, and dexamethasoneRobin Arcani, Régis Costello, Geoffroy Venton et al.|European Journal Of Haematology|2019Cited by 1